Exactitude Consultancy
Home Report Store Categories Primary Research Consulting Services Blog Contact us About Us Terms & Conditions Privacy Policy

Sepsis Diagnostics Market

Jul 2022

Base Year Value ()

x.x %
x.x %

CAGR ()

x.x %
x.x %

Forecast Year Value ()

x.x %
x.x %

Historical Data Period

Largest Region

Forecast Period

Mercado de diagnóstico de sepsis por producto (medios de hemocultivo, reactivos, ensayos, instrumentos, software), método (diagnóstico automatizado, diagnóstico convencional), tipo de prueba (laboratorio, POC), patógeno (bacteriano, viral, fúngico), tecnología (hemocultivo, microbiología, PCR, secuenciación, biomarcadores, microfluídica, inmunoensayos), usuario final (hospital, laboratorio de patología, laboratorios de investigación e institutos académicos) y región (Norteamérica, Europa, Asia Pacífico, Sudamérica, Oriente Medio y África), tendencias globales y pronóstico de 2022 a 2029

Instant access to hundreds of data points and trends

  • Market estimates from 2014-2029
  • Competitive analysis, industry segmentation, financial benchmarks
  • Incorporates SWOT, Porter's Five Forces and risk management frameworks
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Descripción general del mercado de diagnóstico de sepsis


Se espera que el mercado mundial de diagnóstico de sepsis crezca a una tasa anual compuesta del 8,85 % entre 2022 y 2029. Se espera que alcance más de 979,13 millones de dólares en 2029 desde los 469,22 millones de dólares en 2020.


La sepsis es una enfermedad potencialmente mortal que se produce cuando el sistema inmunitario del cuerpo destruye sus propios tejidos en respuesta a una infección. Cuando los sistemas del cuerpo que luchan contra las infecciones se activan, los órganos funcionan mal y de manera inadecuada. La sepsis puede provocar un choque séptico, que es una caída abrupta de la presión arterial que puede provocar daños graves en los órganos e incluso la muerte. El tratamiento con antibióticos y líquidos intravenosos lo antes posible mejora las posibilidades de supervivencia.


Además, la creciente financiación pública y privada para las actividades de investigación de diagnóstico de la sepsis, la creciente carga de enfermedades infecciosas, el creciente número de casos de sepsis y el aumento de los programas gubernamentales para aumentar la conciencia sobre la sepsis probablemente impulsarán la demanda de dispositivos de diagnóstico de la sepsis. Se prevé que el mercado de diagnóstico de la sepsis se desarrolle significativamente durante el período de pronóstico, debido a un aumento en la carga de sepsis y un aumento en la población geriátrica mundial. Los principales impulsores del crecimiento del mercado incluyen un aumento en la financiación gubernamental para los esfuerzos de investigación relacionados con la sepsis, así como un aumento en la prevalencia de enfermedades infecciosas. Por otro lado, se espera que el desarrollo de enfoques de diagnóstico rápido/punto de atención para diagnósticos tempranos de sepsis cree oportunidades lucrativas para los principales participantes de la industria durante todo el período de proyección.


































































ATRIBUTODETALLES
Periodo de estudio2020-2029
Año base2021
Año estimado2022
Año pronosticado2022-2029
Periodo histórico2018-2020
UnidadValor (millones de USD)
SegmentaciónPor producto, por método, por tipo de prueba, por patógeno, por tecnología, por usuario final, por región
 

Por producto


  • Reactivos

  • Ensayo

  • Instrumentos

  •  Software


Por método

  • Diagnóstico automatizado

  • Diagnóstico convencional


Por tipo de prueba

Por patógeno

  • Bacteriano

  • Viral

  • Hongo


Por tecnología

  • Microbiología

  • PCR

  • Secuenciación

  • Biomarcadores

  • Microfluídica

  • Inmunoensayos


Por el usuario final

  • Hospital

  • Laboratorio de patología

  • Laboratorios de investigación e institutos académicos


Por región

  • América del norte

  • Europa

  • Asia Pacífico

  • Sudamerica

  • Ministerio de Asuntos Exteriores



Sin embargo, el alto costo de los instrumentos de diagnóstico automatizados limita la expansión del mercado. La sepsis es una enfermedad potencialmente mortal que debe ser detectada y tratada lo antes posible por expertos en atención médica capacitados. En todo el mundo, existe una escasez crónica de expertos competentes; solo la mitad de los pacientes con sepsis grave que son trasladados por el sistema EMS cuentan con un paramédico. La escasez de paramédicos calificados tiene un impacto en todas las fases de la atención al paciente, incluida la concienciación de la sepsis, la evaluación de los pacientes para detectar la presencia de sepsis y la toma de decisiones adecuadas sobre el tratamiento.


La pandemia de COVID-19 se extendió por todo el mundo y eso interrumpió la cadena de suministro a nivel mundial. Debido al cierre, el proceso de producción de todas las industrias se detuvo, cerró o desvió hacia la recuperación de los pacientes de COVID y eso resultó en una disminución de la demanda de diagnósticos de sepsis en el mercado. La industria de las cámaras médicas ha sufrido como resultado de los retrasos en los procedimientos médicos y las cirugías. A medida que los mercados mundiales se han abierto, se están enfocando en tener más cámaras para la supervisión y se espera que ganen un crecimiento potencial en el mercado de diagnóstico de sepsis.




[título id="attachment_10024" align="aligncenter" width="870"]Sepsis Diagnostics Market | Exactitude Consultancy
Mercado de diagnóstico de sepsis | Exactitude Consultancy
[/subtítulo]

Frequently Asked Questions

• What is the worth of the Sepsis Diagnostics market

The Sepsis Diagnostics market size had crossed USD 32.50 million in 2020 and will observe a CAGR of more than 8.85% up to 2029 driven by the rise in sepsis diseases and diagnostic surgeries in healthcare industry.

• What is the size of the North America Sepsis Diagnostics industry?

North America accounted for a 42% share of the sepsis diagnostics market in 2020 and is expected to maintain its dominance during the forecast period. 

• What are the challenges, drivers and opportunities for the Sepsis Diagnostics market?

Rising number of sepsis occurrences, and growing government programmes to raise sepsis awareness are all likely to drive demand for sepsis diagnostic devices and thus market growth. Development of quick diagnosis/point-of-care approaches for early sepsis diagnoses is expected to create lucrative opportunities to major industry participants. But the high cost of automated diagnostics instruments limits the market expansion.

• Which are the top companies to hold the market share in Sepsis Diagnostics market?

bioMérieux, Becton, Dickinson and Company, Danaher Corporation, T2 Biosystems, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Bruker Corporation, Abbott Laboratories, Immunexpress, Axis-Shield Diagnostics, Quidel Corporation, and others., are among the leading players in the global sepsis diagnostics market.

• Which is the largest regional market for Sepsis Diagnostics Market?

Presence of a highly developed healthcare system, high adoption of innovative sepsis diagnostic technologies among medical professionals, a rising number of surgical procedures, in the North American region, it accounted for a large share of sepsis diagnostics market in 2020 and is expected to maintain its dominance during the forecast period.

• Which region is expected to have the fastest growth rate within the forecast period?

Due to its large patient population, increasing sepsis diagnostics usage in healthcare industry, as well as the rise in geriatric population, Asia-Pacific is expected to have the highest CAGR in coming years.

Sepsis Diagnostics Market Segment Analysis

The global sepsis diagnostics market is segmented by product, method, test type, pathogen, technology, end user and region.

Based on product segment, the sepsis diagnostics market includes Blood Culture Media, Reagents, Assay, Instruments, Software. During the projection period, the blood culture media segment had the greatest market share. This proportion may be ascribed to the increasing use of blood culture media for the diagnosis of sepsis by hospitals and pathology labs, as well as an increase in the market availability of blood culture media.

The sepsis diagnostics market can be classified based on the method, that is Automated Diagnostics, Conventional Diagnostics. Due to the greater cost of automated diagnostics equipment, the traditional diagnostics segment currently leads the market and is likely to stay dominant over the forecast period.

Based on test type segment, the sepsis diagnostics market includes Lab, POC. The laboratory testing segment now leads the market and is projected to do so for the foreseeable future. This is due to the fact that lab testing is more accurate than point-of-care testing for detecting sepsis. Furthermore, the increased dependence of patients and clinicians on laboratory testing drives the growth of the sepsis diagnostic market.

The sepsis diagnostics market can be classified based on the pathogen, that is Bacterial, Viral, Fungal. The bacterial sepsis category held the greatest market share. This increase can be ascribed to an increase in bacterial sepsis cases, an increase in surgical operations, and an increase in the prevalence of HAIs.

Based on technology segment, the sepsis diagnostics market includes Blood Culture, Microbiology, PCR, Sequencing, Biomarkers, Microfluidics, Immunoassays. The blood culture segment held the greatest market share. This proportion can be ascribed to the inexpensive cost of microbiology techniques as well as the widespread usage of blood culture methods for sepsis diagnosis.

Based on end-user segment, the sepsis diagnostics market includes Hospital, Pathology Lab, Research Laboratories & Academic Institutes. The hospitals and specialty clinics have the biggest share of the sepsis diagnostics market. The larger share of this segment can be attributed to the high prevalence of sepsis, as well as the large number of fatalities caused by the illness, the increasing number of patients hospitalized with sepsis, and in-house hospital laboratories performing a large number of blood culture tests to identify blood stream infections (BSIs caused by bacteria, fungi/yeast, or viruses).

[caption id="attachment_10025" align="alignleft" width="680"]Sepsis Diagnostics Market | Exactitude Consultancy
Sepsis Diagnostics Market | Exactitude Consultancy
[/caption]

Sepsis Diagnostics Market Players

The global sepsis diagnostics market key players include bioMérieux, Becton, Dickinson and Company, Danaher Corporation, T2 Biosystems, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Bruker Corporation, Abbott Laboratories, Immunexpress, Axis-Shield Diagnostics, Quidel Corporation, and others.

Various businesses are focusing on organic growth tactics such as new launches, product approvals, and other things like patents and events. Mergers & Acquisitions, partnerships, and collaborations were among the inorganic growth tactics observed in the market. These initiatives such as developing new products and upgrading others, have paved the road for market participants to expand their business. These market players in the sepsis diagnostics market are expected to benefit from attractive growth prospects in the future.

April 12th 2022-bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire Specific Diagnostics, a privately held U.S. based company that has developed a rapid antimicrobial susceptibility test (AST) system that delivers phenotypic AST directly from positive blood cultures.

Who Should Buy? Or Key Stakeholders

  • Government and research organization
  • Investors
  • Trade Associations
  • Pathology labs/Clinics
  • Scientific research organization
  • Healthcare Industry

Sepsis Diagnostics Market Regional Analysis

The sepsis diagnostics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

  • North America: includes the US, Canada, Mexico
  • Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
  • Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
  • South America: includes Brazil, Argentina and Rest of South America
  • Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America has a dominating share in the global sepsis diagnostics market due to well established healthcare industry, rising prevalence of sepsis diseases and diagnostic procedures. Followed by Asia Pacific & Europe, owing to rise in technology advancements, as well as investments by government in funding the healthcare industry and devices.

[caption id="attachment_10026" align="alignleft" width="680"]Sepsis Diagnostics Market | Exactitude Consultancy
Sepsis Diagnostics Market | Exactitude Consultancy
[/caption]

Key Market Segments: Sepsis Diagnostics Market

Sepsis Diagnostics Market by Product, 2020-2029, (USD Million)
  • Blood Culture Media
  • Reagents
  • Assay
  • Instruments
  • Software
Sepsis Diagnostics Market by Method, 2020-2029, (USD Million)
  • Automated Diagnostics
  • Conventional Diagnostics
Sepsis Diagnostics Market by Test Type, 2020-2029, (USD Million)
  • Lab
  • POC
Sepsis Diagnostics Market by Pathogen, 2020-2029, (USD Million)
  • Bacterial
  • Viral
  • Fungal
Sepsis Diagnostics Market by Technology, 2020-2029, (USD Million)
  • Blood Culture
  • Microbiology
  • PCR
  • Sequencing
  • Biomarkers
  • Microfluidics
  • Immunoassays
Sepsis Diagnostics Market by End User, 2020-2029, (USD Million)
  • Hospital
  • Pathology Lab
  • Research Laboratories & Academic Institutes
Sepsis Diagnostics Market by Region, 2020-2029, (USD Million)
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East and Africa
Important Countries in All Regions Are Covered

Key Question Answered

  • What is the current size of the sepsis diagnostics market?
  • What are the key factors influencing the growth of sepsis diagnostics?
  • What is the major end-use industry for sepsis diagnostics?
  • Who are the major key players in the sepsis diagnostics market?
  • Which region will provide more business opportunities for sepsis diagnostics in future?
  • Which segment holds the maximum share of the sepsis diagnostics market?

  1. Introducción

    1. Definición de mercado

    2. Segmentación del mercado

    3. Cronología de la investigación

    4. Supuestos y limitaciones



  2. Metodología de la investigación

    1. Minería de datos

      1. Investigación secundaria

      2. Investigación primaria

      3. Asesoramiento de expertos en la materia



    2. Controles de calidad

      1. Revisión final



    3. Triangulación de datos

      1. Enfoque de abajo hacia arriba

      2. Enfoque de arriba hacia abajo

      3. Flujo de investigación



    4. Fuentes de datos



  3. Resumen ejecutivo

  4. Descripción general del mercado

    1. Perspectivas del mercado mundial de diagnóstico de sepsis

      1. Factores impulsores del mercado

      2. Restricciones del mercado

      3. Oportunidades de mercado



    2. Impacto de la COVID-19 en el mercado de diagnóstico de sepsis

    3. Modelo de las cinco fuerzas de Porter

      1. Amenaza de nuevos participantes

      2. Amenaza de sustitutos

      3. Poder de negociación de los proveedores

      4. Poder de negociación de los clientes

      5. Grado de competencia



    4. Análisis de la cadena de valor de la industria



  5. Mercado mundial de diagnóstico de sepsis por producto (millones de USD)

    1. Reactivos

    2. Ensayo

    3. Instrumentos

    4. Software



  6. Mercado mundial de diagnóstico de sepsis por método (millones de USD)

    1. Diagnóstico automatizado

    2. Diagnóstico convencional



  7. Mercado mundial de diagnóstico de sepsis por tipo de prueba (millones de USD)

    1. Laboratorio

    2. POC



  8. Mercado mundial de diagnóstico de sepsis por patógeno (millones de USD)

    1. Bacteriano

    2. Viral

    3. Hongo



  9. Mercado mundial de diagnóstico de sepsis por tecnología (millones de USD)

    1. Microbiología

    2. PCR

    3. Secuenciación

    4. Biomarcadores

    5. Microfluídica

    6. Inmunoensayos



  10. Mercado mundial de diagnóstico de sepsis por usuario final (millones de USD)

    1. Hospital

    2. Laboratorio de patología

    3. Laboratorios de investigación e institutos académicos



  11. Mercado mundial de diagnóstico de sepsis por región (millones de USD)

    1. América del norte

      1. A NOSOTROS

      2. Canadá

      3. México



    2. Sudamerica

      1. Brasil

      2. Argentina

      3. Colombia

      4. Resto de Sudamérica



    3. Europa

      1. Alemania

      2. Reino Unido

      3. Francia

      4. Italia

      5. España

      6. Rusia

      7. Resto de Europa



    4. Asia Pacífico

      1. India

      2. Porcelana

      3. Japón

      4. Corea del Sur

      5. Australia

      6. Sudeste asiático

      7. Resto de Asia Pacífico



    5. Oriente Medio y África

      1. Emiratos Árabes Unidos

      2. Arabia Saudita

      3. Sudáfrica

      4. Resto de Oriente Medio y África







  1. Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)

    1. Biomérieux

    2. Becton, Dickinson And Company

    3. Danaher Corporation

    4. T2 Biosystems

    5. Luminex

    6. Roche Diagnostics

    7. Thermo Fisher Scientific

    8. Bruker Corporation

    9. Abbott Laboratories

    10. Immunexpress

    11. Axis-Shield Diagnostics

    12. Quidel Corporation                                       *The Company List Is Indicative




LIST OF TABLES


TABLE 1               GLOBAL SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 2               GLOBAL SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 3               GLOBAL SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 4               GLOBAL SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 5               GLOBAL SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 6               GLOBAL SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 7               GLOBAL SEPSIS DIAGNOSTICS MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 8               US SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 9               US SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 10            US SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 11            US SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 12            US SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 13            US SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 14            CANADA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 15            CANADA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 16            CANADA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 17            CANADA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 18            CANADA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 19            CANADA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 20            MEXICO SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 21            MEXICO SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 22            MEXICO SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 23            MEXICO SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 24            MEXICO SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 25            MEXICO SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 26            BRAZIL SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 27            BRAZIL SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 28            BRAZIL SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 29            BRAZIL SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 30            BRAZIL SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 31            BRAZIL SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 32            ARGENTINA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 33            ARGENTINA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 34            ARGENTINA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 35            ARGENTINA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 36            ARGENTINA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 37            ARGENTINA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 38            COLOMBIA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 39            COLOMBIA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 40            COLOMBIA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 41            COLOMBIA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 42            COLOMBIA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 43            COLOMBIA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 44            REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 45            REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 46            REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 47            REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 48            REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 49            REST OF SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 50            INDIA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 51            INDIA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 52            INDIA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 53            INDIA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 54            INDIA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 55            INDIA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 56            CHINA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 57            CHINA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 58            CHINA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 59            CHINA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 60            CHINA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 61            CHINA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 62            JAPAN SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 63            JAPAN SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 64            JAPAN SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 65            JAPAN SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 66            JAPAN SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 67            JAPAN SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 68            SOUTH KOREA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 69            SOUTH KOREA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 70            SOUTH KOREA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 71            SOUTH KOREA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 72            SOUTH KOREA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 73            SOUTH KOREA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 74            AUSTRALIA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 75            AUSTRALIA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 76            AUSTRALIA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 77            AUSTRALIA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 78            AUSTRALIA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 79            AUSTRALIA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 80            SOUTH-EAST ASIA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 81            SOUTH-EAST ASIA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 82            SOUTH-EAST ASIA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 83            SOUTH-EAST ASIA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 84            SOUTH-EAST ASIA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 85            SOUTH-EAST ASIA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 86            REST OF ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 87            REST OF ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 88            REST OF ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 89            REST OF ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 90            REST OF ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 91            REST OF ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 92            GERMANY SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 93            GERMANY SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 94            GERMANY SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 95            GERMANY SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 96            GERMANY SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 97            GERMANY SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 98            UK SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 99            UK SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 100          UK SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 101          UK SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 102          UK SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 103          UK SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 104          FRANCE SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 105          FRANCE SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 106          FRANCE SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 107          FRANCE SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 108          FRANCE SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 109          FRANCE SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 110          ITALY SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 111          ITALY SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 112          ITALY SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 113          ITALY SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 114          ITALY SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 115          ITALY SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 116          SPAIN SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 117          SPAIN SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 118          SPAIN SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 119          SPAIN SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 120          SPAIN SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 121          SPAIN SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 122          RUSSIA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 123          RUSSIA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 124          RUSSIA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 125          RUSSIA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 126          RUSSIA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 127          RUSSIA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 128          REST OF EUROPE SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 129          REST OF EUROPE SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 130          REST OF EUROPE SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 131          REST OF EUROPE SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 132          REST OF EUROPE SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 133          REST OF EUROPE SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 134          UAE SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 135          UAE SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 136          UAE SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 137          UAE SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 138          UAE SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 139          UAE SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 140          SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 141          SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 142          SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 143          SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 144          SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 145          SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 146          SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 147          SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 148          SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 149          SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 150          SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 151          SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 152          REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 153          REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET BY METHOD (USD MILLIONS) 2020-2029

TABLE 154          REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET BY TEST TYPE (USD MILLIONS) 2020-2029

TABLE 155          REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET BY PATHOGEN (USD MILLIONS) 2020-2029

TABLE 156          REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 157          REST OF MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

LIST OF FIGURES


FIGURE 1       MARKET DYNAMICS

FIGURE 2       MARKET SEGMENTATION

FIGURE 3       REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4       DATA TRIANGULATION

FIGURE 5       BOTTOM-UP APPROACH

FIGURE 6       TOP-DOWN APPROACH

FIGURE 7       RESEARCH FLOW

FIGURE 8       GLOBAL SEPSIS DIAGNOSTICS MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 9       GLOBAL SEPSIS DIAGNOSTICS MARKET BY METHOD, USD MILLION, 2020-2029

FIGURE 10     GLOBAL SEPSIS DIAGNOSTICS MARKET BY TEST TYPE, USD MILLION, 2020-2029

FIGURE 11     GLOBAL SEPSIS DIAGNOSTICS MARKET BY PATHOGEN, USD MILLION, 2020-2029

FIGURE 12     GLOBAL SEPSIS DIAGNOSTICS MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 13     GLOBAL SEPSIS DIAGNOSTICS MARKET BY END USER, USD MILLION, 2020-2029

FIGURE 14     GLOBAL SEPSIS DIAGNOSTICS MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 15     PORTER’S FIVE FORCES MODEL

FIGURE 16     NORTH AMERICA SEPSIS DIAGNOSTICS MARKET SNAPSHOT

FIGURE 17     EUROPE SEPSIS DIAGNOSTICS MARKET SNAPSHOT

FIGURE 18     ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET SNAPSHOT

FIGURE 19       SOUTH AMERICA SEPSIS DIAGNOSTICS MARKET SNAPSHOT

FIGURE 20       MIDDLE EAST & AFRICA SEPSIS DIAGNOSTICS MARKET SNAPSHOT

FIGURE 21          BIOMÉRIEUX: COMPANY SNAPSHOT

FIGURE 22          BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

FIGURE 23          DANAHER CORPORATION: COMPANY SNAPSHOT

FIGURE 24          T2 BIOSYSTEMS: COMPANY SNAPSHOT

FIGURE 25          LUMINEX: COMPANY SNAPSHOT

FIGURE 26          ROCHE DIAGNOSTICS: COMPANY SNAPSHOT

FIGURE 27          THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 28          BRUKER CORPORATION: COMPANY SNAPSHOT

FIGURE 29          ABBOTT LABORATORIES: COMPANY SNAPSHOT

FIGURE 30          IMMUNEXPRESS: COMPANY SNAPSHOT

FIGURE 31          AXIS-SHIELD DIAGNOSTICS: COMPANY SNAPSHOT

FIGURE 32          QUIDEL CORPORATION: COMPANY SNAPSHOT

DOWNLOAD FREE SAMPLE REPORT

Kindly share your specific requirement (if any)
3564

License Type

Single User

US$ 3499

Multi User

US$ 4499

Corporate User

US$ 5499

Get Sample to Email

SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

Proactive

We manage our resources 24/7 to identify issues and address them before they become problems

Quality & Reliability

We are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach

6 Major regions and 40+ countries level analysis accomplished

Competitive Pricing

Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

In-Depth Database

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Customer Support

Complete pre and post sales support.

Safe & Secure

Safe & Secure

Complete secure payment process.